These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19008574)

  • 1. Detection of extended spectrum beta-lactamase from clinical isolates in Davangere.
    Sridhar Rao PN; Basavarajappa KG; Krishna GL
    Indian J Pathol Microbiol; 2008; 51(4):497-9. PubMed ID: 19008574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
    Bakthavatchalu S; Shakthivel U; Mishra T
    Pan Afr Med J; 2013; 14():28. PubMed ID: 23504148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M; Mouttet B; Bloemberg GV
    J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a phenotypic screening strategy for emerging β-lactamases in Gram-negative bacilli.
    Willems E; Verhaegen J; Magerman K; Nys S; Cartuyvels R
    Int J Antimicrob Agents; 2013 Feb; 41(2):99-109. PubMed ID: 23280443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Böttger EC; Hombach M
    Clin Microbiol Infect; 2012 Dec; 18(12):1194-204. PubMed ID: 22264296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
    Khan MK; Thukral SS; Gaind R
    Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.
    Poulou A; Grivakou E; Vrioni G; Koumaki V; Pittaras T; Pournaras S; Tsakris A
    J Clin Microbiol; 2014 May; 52(5):1483-9. PubMed ID: 24574283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.
    Robin F; Delmas J; Schweitzer C; Bonnet R
    Clin Microbiol Infect; 2008 Feb; 14(2):148-54. PubMed ID: 18076663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010.
    Huang CC; Chen YS; Toh HS; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Xu Y; Ni Y; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S4-10. PubMed ID: 22749058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Singh RM; Singh HL
    J Infect Dev Ctries; 2014 Apr; 8(4):408-15. PubMed ID: 24727505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamases: a clinical update.
    Paterson DL; Bonomo RA
    Clin Microbiol Rev; 2005 Oct; 18(4):657-86. PubMed ID: 16223952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.
    Spanu T; Sanguinetti M; Tumbarello M; D'Inzeo T; Fiori B; Posteraro B; Santangelo R; Cauda R; Fadda G
    J Clin Microbiol; 2006 Sep; 44(9):3257-62. PubMed ID: 16954257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon.
    Gangoué-Piéboji J; Bedenic B; Koulla-Shiro S; Randegger C; Adiogo D; Ngassam P; Ndumbe P; Hächler H
    J Clin Microbiol; 2005 Jul; 43(7):3273-7. PubMed ID: 16000447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae.
    Garrec H; Drieux-Rouzet L; Golmard JL; Jarlier V; Robert J
    J Clin Microbiol; 2011 Mar; 49(3):1048-57. PubMed ID: 21248086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.